Current Report
Filed: 2026-01-13
Key Insights
- Rick Orman, a director, has resigned from the CannaPharmaRX, Inc. Board of Directors with immediate effect, although the resignation was not due to any dispute or disagreement with the company.
- The company issued a press release on January 12, 2026 providing corporate updates and outlining its 2026 growth strategy, indicating potential strategic developments for investors to watch.
- As an 8-K filing, this report discloses material events that could impact the company, which investors should consider when evaluating the stock.